General Information |
| Clinical trials phase |
Phase 1 |
| Start date (estimated) |
2024-12-27 |
| End date (estimated) |
2028-12-31 |
| Clinical feature |
| Label |
cervical cancer |
| Link |
http://purl.obolibrary.org/obo/DOID_4362 |
| Description |
A female reproductive organ cancer that is located_in the cervix. |
|
Administrative Information |
| Other study identifiers |
| Name |
jRCT2033240591 |
| Description |
Japan Registry of Clinical Trials (jRCT) |
|
| Source weblink |
https://jrct.niph.go.jp/en-latest-detail/jRCT2033240591 |
| Public contact |
| Email |
rejt-h01@juntendo.ac.jp |
| Public email |
rejt-h01@juntendo.ac.jp |
| First name |
Yasuhisa |
| Last name |
Terao |
| Phone |
+81-3-3813-3111 |
| City |
Tokyo |
| Country |
|
| Address freetext |
Hongo 2-1-1, Bunkyo-city, Tokyo, Japan |
|
Cells |
| Which differentiated cell type is used |
| Label |
cytotoxic T cell |
| Link |
http://purl.obolibrary.org/obo/CL_0000910 |
| Description |
A mature T cell that differentiated and acquired cytotoxic function with the phenotype perforin-positive and granzyme-B positive. |
|
Recruitment |
| Recruitment Status |
Recruiting |
| Estimated number of participants |
12 |
